Healthcare

The case for investing in harm reduction in Eastern Europe and Central Asia

March 10, 2021

Global

The case for investing in harm reduction in Eastern Europe and Central Asia

March 10, 2021

Global
Dr Chrissy Bishop
Editor, The Economist Intelligence Unit

Chrissy is an Associate in the Health Policy and Clinical Evidence team. Her areas of expertise are epidemiology and biostatistics, longitudinal data analysis and health systems. Chrissy worked as a Senior Occupational Therapist in the NHS and Operations Manager for a private health care company before joining the Health Policy and Clinical Evidence team.    

The case for investing in harm reduction in Eastern Europe and Central Asia

Inforaphic Mobile Image

The case for investing in harm reduction in Eastern Europe and Central Asia

Receive forward-looking perspectives from our editors - Subscribe now for our Weekly Digest